Acute myocardial infarction with ST-segment elevation
Mario Alberto García-Esquivel1, Fernando Huerta-Liceaga1, Luis Alexander Martínez-Garzón1
1Petróleos Mexicanos (PEMEX), Hospital Central Sur de Alta Especialidad, Servicio de Cardiología, Subdivisión de Cardiología Intervencionista.
Insights
This review discusses managing ST-segment elevation myocardial infarction (STEMI) during the COVID-19 pandemic. It synthesizes current knowledge to guide treatment decisions for cardiac patients facing this global health emergency.
Area of Science:
- Cardiology
- Infectious Diseases
- Public Health
Background:
- Coronavirus disease 2019 (COVID-19), caused by SARS-CoV-2, presents a global health emergency.
- COVID-19 significantly impacts patients with pre-existing cardiac conditions.
- Standard emergency treatment for ST-segment elevation myocardial infarction (STEMI) involves urgent reperfusion, but COVID-19 complicates established protocols.
Purpose of the Study:
- To review and synthesize current literature on managing STEMI in COVID-19 patients.
- To provide evidence-based guidance for clinical decision-making during the pandemic.
- To address the lack of established guidelines for this specific patient population.
Main Methods:
- Systematic review of relevant articles published during the COVID-19 pandemic.
- Analysis of studies focusing on STEMI management in the context of SARS-CoV-2 infection.
- Synthesis of findings to identify key conclusions and recommendations.
Main Results:
- The review highlights the challenges and adaptations in STEMI care during the pandemic.
- It identifies critical factors influencing treatment choices, such as resource availability and patient risk stratification.
- Key findings address the integration of COVID-19 screening and management within STEMI protocols.
Conclusions:
- Urgent management of STEMI remains crucial, even amidst the COVID-19 pandemic.
- Adaptations in reperfusion strategies and hospital protocols are necessary.
- Further research and updated guidelines are essential for optimizing STEMI care during global health crises.
Abstract:
Coronavirus disease 19 (COVID-19) is the infection caused by the SARS-CoV-2 virus and it has become a global emergency. The disease has a hughe impact on cardiopaths. Under regular conditions, patients entering the emergency room with a ST-segment elevation myocardial infarction (STEMI) must be urgently treated with reperfusion strategy. However, due to the scarce knowledge about COVID-19, there have not being yet established the guidelines for management of patients with STEMI and COVID-19. In this review we expose the main conclusions of relevant articles published about STEMI management during this pandemic. We aim to provide a review to guide the decisions about the management of STEMI during the COVID-19 emergency.
More Related Videos
Related Concept Videos
Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Acute Coronary Syndrome III: Diagnostic Studies
Myocarditis II: Clinical Features and Diagnostic Tests
Myocarditis I: Introduction
Acute Coronary Syndrome IV: Interprofessional Care


